Lipoprotein(a): An independent risk factor for ischemic heart disease that is dependent on triglycerides in subjects with type 2 diabetes mellitus

Lipids in Health and Disease

Volumn 6, Issue , 2007, Pages

  AlBahrani, Ali ^a   Alkindi, Mohammed ^b   Marks, Eileen ^c   AlYahyaee, Said ^b   Shenkin, Alan ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HEMOGLOBIN A1C; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; HEART MUSCLE ISCHEMIA; MIDDLE AGED; STATISTICAL ANALYSIS;

ADULT; AGED; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS; TRIGLYCERIDES;

EID: 38749115813     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-6-26     Document Type: Article

References (25)

1. Protein composition of Lp(a) lipoprotein from human plasma. G Utermann W Weber, FEBS Lett 1983 154 357 361 10.1016/0014-5793(83)80182-3 6219896
2. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patient with diabetes. T Hiraga T Kobayashi M Okubo K Nakanishi T Sugimoto Ohashi T Murase, Diabetes Care 1995 18 241 244 10.2337/diacare.18.2.241 7729305
3. Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. WY Craig LM Neveux GE Palomaki MM Cleveland JE Haddow, Clin Chem 1998 44 2301 6 9799757
4. Lipids, lipoproteins and apolipoprotein (a) isoforms in type 2 diabetic patients. P Calmarza JC Vella, J Cardiovasc Risk 1999 6 171 5 10463144
5. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart artery disease in Type 2 diabetic patients and non-diabetic subjects. C Gazzaruso A Garzaniti C Falcone D Geroldi G Finardi P Fratino, Diabet Med 2001 18 589 94 10.1046/j.1464-5491.2001.00536.x 11553191
6. Lipoprotein (a) in health and disease. F Kronenberg A Steinmetz GM Kostner H Dieplinger, Crit Rev Clin Lab Sci 1996 33 495 43 10.3109/ 10408369609080056 8989507
7. Insulin and 2-Hour Glucose Are Inversely Related to Lp(a) Concentrations Controlled for LPA Genotype. D Rainwater S Haffner, Arterioscler Thromb Vasc Biol 1998 18 1335 41 9714142
8. Type of diabetes and waist-hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients. HM Nawawi M Muhajir YC Kian WN Mohamud K Yusoff BA Khalid, Diabetes Res Clin Pract 2002 56 221 7 10.1016/S0168-8227(02)00009-8 11947970
9. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus. S Habib M Aslam, Saudi Med J 2003 24 647 5 12847596
10. Lipids and Lp(a) levels and coronary artery disease in subjects with non-insulin dependent diabetes mellitus. T O'Brien T Nguyen J Harrison K Bailey P Dyck B Kottke, Mayo Clin Proc 1994 69 430 5 8170193
11. Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes. M Aamaklar K Lalic N Rajkovic D Trifunovic M Dragasevic L Popovic D Draskovic N Laic A Jotic O Vasovic L Lukic T Milicic T Potpara, Vojnosanit Pregl 2005 62 529 36 16171015
12. Plasma lipoprotein(a) in Turkish NIDDM patients with and without vascular diabetic complications. C Erem O Deger M Bostan A Orem M Sonmez S Ulus M Telatar, Acta Cardiol 1999 54 203 7 10511896
13. A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes. I Shai M Schulze J Manson M Stampfer N Rifai F Hu, Diabetologia 2005 48 1469 76 10.1007/s00125-005-1814-3 15971061
14. Lp(a) glycoprotein phenotypes: inhertance and relation to Lp(a)-lipoprotein concentrations in plasma. G Utermann H Menzel H Kraft H Duba H Kemmleer C Seitz, J Clin Invest 1987 80 458 65 2956279
15. Efffects of NIDDM on lipoprotein(a) and apoliporprotein(a) size. D Rainwater J MaCluer M Stern J VandeBerg S Hafffner, Diabetes 1994 43 942 946 10.2337/diabetes.43.7.942 8013760
16. Lipoprotein (a). PN Durrington, Baillieres Clin Endocrinol Metab 1995 9 4 773 795 10.1016/S0950-351X(95)80145-6 8593125
17. Differential influence of LDL cholesterol and Triglycerides on Lipoprotein (a) Concentrations in Diabetic Patients. C Hernandez P Chacon L Garcia-Pascual R Simo, Diabetes Care 2001 24 350 355 10.2337/diacare.24.2.350 11213891
18. Apolipoprotein B and A-1 values in 127,576 Swedish males and female, standardized according to the World Organization -International Federation of Clinical Chemistry First International Reference Materials. I Jungner S Marcovina G Walldius I Holme W Kolar, Clin Chem 1998 44 1641 49 9702950
19. Clinical Investigation and Statistics in Laboratory Medicine. R Jones B Payne, (Association of Clinical Biochemists) 1997
20. Serum lipoprotein(a) concentration as a cardiovascular risk factors in Kuwaiti type 2 diabetic patients. NA Abdella OA Mojiminiyi AO Akanji H Al-Mohammadi MA Moussa, J Diabetes Complications 2001 15 5 270 276 10.1016/S1056-8727(01)00162-3 11522503
21. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipidaemia. C Sandholzer G Feussner J Brunzell G Utermann, J Clin Invest 1992 90 1958 65 1430218
22. Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Goldberg, J Clin Endocrinol Metab 2001 86 3 965 971 10.1210/jc.86.3.965 11238470
23. The effect of rosiglitazone on serum Lp(a) levels in Korean patients with type 2 diabetes. S Ko K Song Y Ahn S Yoo H Son K Yoon B Cha K Lee H Son S Kang, Metabolism 2003 52 731 40 10.1016/S0026-0495(03)00033-7 12800099
24. Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. U Lundstam J Herlitz T Karlsson T Linden O Wiklund, J Intern Med 2002 251 111 8 10.1046/j.1365-2796. 2002.00937.x 11905586
25. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients. C Gazzaruso R Bruno A Pujia E De Amici P Fratio SB Solerte A Garzaniti, Int J Cardiol 2006 108 3 354 358 10.1016/j.ijcard.2005.05.022 15961173